• Alligator Bioscience held an extraordinary general meeting today, adopting amendments to the articles to reset limits for share capital.
• Share capital reductions were adopted: SEK 112.38 million to cover losses, then SEK 10.1 million to SEK 3.14 million for unrestricted equity.
• Resolutions authorize the reductions without share redemption; execution is not confirmed, while the quota value is set to fall to SEK 0.005.
• Shareholders adopted the board’s rights issue of units, targeting about SEK 125.6 million gross; record date Sept. 2; subscription Sept. 4-18.
• Meeting authorized issues to guarantors and a separate free warrant issue to Fenja Capital II A/S; implementation is not confirmed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alligator Bioscience AB published the original content used to generate this news brief on August 26, 2026, and is solely responsible for the information contained therein.